EUVIMEDEUVIMED entdecken
Crossref

Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML

Martin S. Tallman

Evidence-based Oncology · 2000

DOI: 10.1054/ebon.2000.0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence-based Oncology, 2000. Verfasst von Martin S. Tallman. Die Arbeit nennt 3 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tallman, M. S. (2000). Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML. Evidence-based Oncology. https://doi.org/10.1054/ebon.2000.0012

Vancouver

Tallman MS. Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML. Evidence-based Oncology. 2000. doi:10.1054/ebon.2000.0012

BibTeX
@article{Tallman2000,
  author = {Tallman, Martin S.},
  title = {Double induction with high-dose cytarabine is a safe and effective strategy for delivering early intensification treatment for AML},
  journal = {Evidence-based Oncology},
  year = {2000},
  doi = {10.1054/ebon.2000.0012}
}
Kostenlos starten →